Last reviewed: May 30, 2026
Last updated: May 30, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
NAD+ (nicotinamide adenine dinucleotide) is available online through telehealth platforms, IV clinics, and supplement retailers, but sourcing from licensed healthcare providers significantly reduces safety and quality risks. The telehealth NAD+ market has expanded rapidly without consistent clinical standards, making provider vetting essential.
Whether NAD+ therapy makes sense for you depends on your individual metabolic profile, underlying health goals, and how it integrates with your broader wellness strategy. Understanding your genetic predispositions and biomarker patterns can help you and your provider evaluate whether NAD+ aligns with your personalized health approach.
Legitimate Telehealth NAD+ Sources: Provider Verification Framework
Legitimate NAD+ telehealth providers must hold valid medical licenses, operate in compliance with state pharmacy regulations, and work with licensed compounding or pharmaceutical suppliers. Many telehealth platforms lack transparent credentialing; verify provider licensure through state medical boards and confirm they require medical history review before prescribing.
Red flags include no physician consultation, guaranteed results, extremely low pricing, and lack of transparent sourcing information. Reputable providers offer clear dosing protocols, discuss potential side effects, and adjust treatment based on your individual health status and lab markers.
NAD+ Dosing, Routes, and Clinical Evidence: What the Research Shows
NAD+ is available as oral supplements, IV infusions, and intramuscular injections through telehealth. Clinical evidence for NAD+ effectiveness remains limited; most human studies are small and focus on specific conditions like mitochondrial disease or age-related cognitive decline. Oral NAD+ has poor bioavailability; IV and IM routes bypass this limitation but require prescriber oversight.
| NAD+ Route |
Bioavailability Concern |
Clinical Evidence Base |
Provider Oversight Required |
| Oral NAD+ supplements |
Low (15–30% absorption) |
Limited; mixed results in aging studies |
Optional if OTC supplement |
| IV NAD+ infusions |
High (direct circulation) |
Small trials; some mitochondrial disease benefit |
Physician and licensed infusion center |
| IM NAD+ injections |
High (intramuscular depot) |
Minimal human data; mostly anecdotal |
Physician prescription and nurse administration |
| NAD+ precursors (NMN, NR) |
Moderate (20–40%) |
Some aging and energy studies; mixed outcomes |
Optional if OTC; provider can guide |
Biomarker Context: Evaluating Your Individual NAD+ Need
NAD+ levels naturally decline with age, particularly in tissues with high energy demand like muscle, brain, and heart. However, biomarker measurement of NAD+ is technically challenging and rarely done in standard clinical practice. Blood NAD+ levels do not reliably predict tissue levels or treatment response, so decisions are typically based on clinical symptoms and goals rather than lab confirmation.
If you suspect energy deficit, cognitive sluggishness, or age-related decline, a comprehensive metabolic panel, fasting glucose, lipid profile, and energy-marker assessment (lactate, pyruvate) can provide context for whether NAD+ therapy is clinically justified. Your provider should evaluate these markers alongside your health history before recommending NAD+ supplementation.
Safety, Side Effects, and Who Should Consider NAD+ Therapy
NAD+ is generally well-tolerated, but side effects include flushing, nausea, headache, and in rare cases, liver enzyme elevation. Oral precursors may cause GI distress. IV infusions carry standard infusion risks: infection, phlebitis, or allergic reaction if impurities are present. Individuals with active cancer, uncontrolled psychiatric conditions, or certain metabolic disorders should consult their physician before starting NAD+.
NAD+ therapy is most commonly considered by individuals seeking cognitive enhancement, energy optimization, or mitochondrial support, often as part of broader longevity or biohacking strategies. However, robust clinical evidence supporting these uses is limited. Always discuss your motivation, baseline health status, and expected timeline with a qualified provider before committing to a course of NAD+ treatment.
How PlexusDx Supports a More Personalized Approach
While NAD+ exists outside the GLP-1 and peptide pathway space, PlexusDx's precision-wellness approach recognizes that metabolic optimization is interconnected. If you're considering NAD+ therapy as part of a broader metabolic health strategy, understanding your genetic predispositions in energy metabolism and mitochondrial pathways may help provide context for whether NAD+ fits your personalized health plan.
PlexusDx offers the Precision Peptide Genetic Test, which reveals predispositions in key metabolic and peptide pathways, including markers related to energy metabolism and mitochondrial efficiency. While this test focuses on peptide genetic variants, the metabolic insights it provides can support a more comprehensive conversation with your healthcare provider about whether adjunctive therapies like NAD+ align with your genetic profile.
If you are exploring multiple therapies for metabolic optimization—including GLP-1 compounds for weight management, metabolic health, or other goals—genetic and biomarker context can help your provider build a coordinated strategy. PlexusDx encourages discussion with your provider about how NAD+, genetic predispositions, and other interventions work together in your personalized wellness plan.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $179-$229/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is NAD+ available without a prescription online?
NAD+ oral supplements are available OTC, but IV and IM NAD+ require a physician prescription and must be administered by licensed professionals. Verify that any online NAD+ offering involves a licensed provider consultation.
What does clinical evidence say about NAD+ for energy and aging?
Evidence is limited. Some small studies show NAD+ may support mitochondrial function in specific disease states, but human trials for general aging and energy are sparse and often show mixed results. More research is needed.
How does PlexusDx's genetic test relate to NAD+ therapy decisions?
PlexusDx's Precision Peptide Genetic Test focuses on peptide pathways, not NAD+ metabolism directly. However, insights into mitochondrial and energy-related variants can support broader metabolic conversations with your provider about whether NAD+ fits your profile.
What are the main safety risks of online NAD+ therapy?
Risks include impure compounded products, improper infusion technique, and undisclosed interactions with other medications. Always verify provider licensure and obtain a complete medical review before starting NAD+ therapy.
Should I get NAD+ levels tested before starting therapy?
Standard NAD+ blood testing is unreliable and rarely recommended. Your provider should base NAD+ consideration on clinical symptoms, metabolic markers (glucose, energy status), and health goals rather than NAD+ level alone.
Related Reading
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
MIC-B12 Injections Reviews Injections: How They Work, Format
What Is MIC B12: Clinical Role in Metabolic Health and Wellness Optimization